HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Maria Chiara Tisi Selected Research
Maria Chiara Tisi Research Topics
Disease
10
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2024 - 03/2012
8
B-Cell Lymphoma (Lymphoma, B Cell)
03/2024 - 01/2016
4
COVID-19
02/2023 - 11/2022
3
Virus Diseases (Viral Diseases)
01/2023 - 01/2021
3
Infections
11/2022 - 12/2020
3
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022 - 07/2014
3
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2021 - 01/2021
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2014 - 03/2012
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023
1
Pneumonia (Pneumonitis)
11/2022
1
Breakthrough Infections
02/2022
1
Aspergillosis
02/2022
1
Hematologic Neoplasms (Hematological Malignancy)
01/2022
1
Graft vs Host Disease (Graft-Versus-Host Disease)
12/2021
1
Opportunistic Infections (Opportunistic Infection)
01/2021
1
Bacterial Infections (Bacterial Infection)
01/2021
1
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2021
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2021
1
Neoplasms (Cancer)
01/2021
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
06/2019
1
Disease Progression
06/2019
1
Trisomy (Trisomies)
06/2019
1
Lymphoma (Lymphomas)
01/2018
1
Overweight
01/2018
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2015
1
Spinal Cord Diseases
01/2015
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2015
1
Anemia
02/2014
1
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
07/2011
1
Hodgkin Disease (Hodgkin's Disease)
07/2011
Drug/Important Bio-Agent (IBA)
4
Rituximab (Mabthera)
FDA Link
12/2022 - 03/2012
4
Cytarabine (Cytosar-U)
FDA Link
Generic
11/2022 - 01/2018
3
obinutuzumab
IBA
05/2024 - 01/2021
3
Chimeric Antigen Receptors
IBA
01/2023 - 12/2021
3
Bendamustine Hydrochloride
FDA Link
12/2022 - 12/2018
3
Antiviral Agents (Antivirals)
IBA
01/2020 - 11/2017
2
venetoclax
IBA
01/2023 - 01/2021
2
idelalisib
IBA
01/2022 - 01/2021
2
Biomarkers (Surrogate Marker)
IBA
01/2016 - 07/2014
2
Interleukin-6 (Interleukin 6)
IBA
02/2014 - 03/2012
1
axicabtagene ciloleucel
IBA
03/2024
1
tisagenlecleucel
IBA
01/2024
1
Anthracyclines
IBA
10/2023
1
Monoclonal Antibodies
IBA
01/2023
1
polatuzumab vedotin
IBA
12/2022
1
Steroids
IBA
11/2022
1
posaconazole
FDA Link
02/2022
1
Agammaglobulinaemia Tyrosine Kinase
IBA
12/2021
1
ibrutinib
IBA
01/2021
1
Proteins (Proteins, Gene)
FDA Link
01/2021
1
blinatumomab
IBA
01/2021
1
Neoplasm Antigens (Tumor Antigens)
IBA
01/2021
1
Brentuximab Vedotin
IBA
12/2020
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
06/2019
1
Hemoglobins (Hemoglobin)
IBA
01/2018
1
Carmustine (FIVB)
FDA Link
01/2018
1
Melphalan (Alkeran)
FDA Link
Generic
01/2018
1
Albumins
IBA
01/2018
1
Etoposide (VP 16)
FDA Link
Generic
01/2018
1
25-hydroxyvitamin D
IBA
01/2018
1
hydroxide ion
IBA
01/2018
1
DNA (Deoxyribonucleic Acid)
IBA
01/2016
1
nelarabine (506U78)
FDA Link
01/2015
1
Hepcidins
IBA
02/2014
1
Erythropoietin
FDA Link
02/2014
1
Cytokines
IBA
03/2012
1
Azacitidine (5 Azacytidine)
FDA Link
07/2011
Therapy/Procedure
9
Therapeutics
02/2023 - 07/2011
7
Drug Therapy (Chemotherapy)
11/2022 - 03/2012
3
Stem Cell Transplantation
12/2021 - 01/2015
1
Immunotherapy
01/2022
1
Salvage Therapy
01/2021
1
Time-to-Treatment
06/2019
1
Hematopoietic Stem Cell Transplantation
01/2018
1
Radiotherapy
01/2015